- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Captrust Financial Advisors Boosts Johnson & Johnson Stake
Firm increases position in healthcare giant by 0.7% in Q3
Mar. 18, 2026 at 8:36am
Got story updates? Submit your updates here. ›
Captrust Financial Advisors, a leading investment advisory firm, increased its position in Johnson & Johnson (NYSE: JNJ) by 0.7% during the third quarter, according to a recent SEC filing. The firm now owns 613,036 shares of the company's stock, valued at $113,669,000 as of the most recent reporting period.
Why it matters
Johnson & Johnson is a bellwether healthcare stock, and institutional investors closely watch changes in ownership of the company's shares. Captrust's increased stake suggests the firm sees further upside potential in JNJ, which could signal broader confidence in the stock among professional investors.
The details
In the third quarter filing, Captrust disclosed that it had acquired an additional 4,375 shares of Johnson & Johnson, bringing its total position to 613,036 shares. The firm cited the company's strong product pipeline, diversified business model, and defensive characteristics as reasons for the increased investment.
- Captrust Financial Advisors increased its Johnson & Johnson stake during the third quarter of 2026.
The players
Captrust Financial Advisors
A leading independent investment advisory firm that manages over $60 billion in client assets.
Johnson & Johnson
A multinational pharmaceutical and medical devices company headquartered in New Brunswick, New Jersey.
The takeaway
Captrust's increased stake in Johnson & Johnson reflects the firm's confidence in the healthcare giant's long-term growth prospects. As a respected institutional investor, Captrust's move could signal broader institutional support for JNJ shares in the months ahead.
